Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-96, 2005. ,
DOI : 10.1056/NEJMoa043330
Cancer stem cells and survival pathways, Cell Cycle, vol.7, issue.10, pp.1371-1379, 2008. ,
DOI : 10.4161/cc.7.10.5954
Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients??? survival in glioblastoma multiforme, Oncogene, vol.18, issue.69, pp.4999-5009, 2007. ,
DOI : 10.1038/sj.onc.1210303
Eicosanoids and cancer, Nature Reviews Cancer, vol.133, issue.3, pp.181-93, 2010. ,
DOI : 10.1038/nrc2809
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations, Cancer Res, vol.61, pp.4375-81, 2001. ,
COX-2 overexpression increases malignant potential of human glioma cells through Id1, Oncotarget, vol.5, issue.5, pp.1241-52, 2014. ,
DOI : 10.18632/oncotarget.1370
New insights into COX-2 biology and inhibition, Brain Research Reviews, vol.48, issue.2, pp.352-361, 2005. ,
DOI : 10.1016/j.brainresrev.2004.12.024
Bioactive lipids and the control of Bax pro-apoptotic activity, Cell Death and Disease, vol.3, issue.5, p.1266, 2014. ,
DOI : 10.1073/pnas.1300677110
Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention, Cancer Prevention Research, vol.4, issue.11, pp.1728-1763, 2011. ,
DOI : 10.1158/1940-6207.CAPR-11-0166
The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas, Neuropathology, vol.47, issue.2, pp.156-65, 2009. ,
DOI : 10.1111/j.1440-1789.2008.00963.x
induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma, Neuro-Oncology, vol.18, issue.10, pp.1379-89, 2016. ,
DOI : 10.1093/neuonc/now049
The role of the EP receptors for prostaglandin E2 in skin and skin cancer, Cancer and Metastasis Reviews, vol.4, issue.1, pp.465-80, 2011. ,
DOI : 10.1007/s10555-011-9317-9
Inhibition of Human Glioma Cell Growth by a PHS-2 Inhibitor, NS398, and a Prostaglandin E Receptor Subtype EP1-selective Antagonist, SC51089, Journal of Neuro-Oncology, vol.66, issue.3, pp.285-92, 2004. ,
DOI : 10.1023/B:NEON.0000014537.15902.73